January 7, 2020
Eisai said on January 6 that it has launched its antiepileptic agent Fycompa (perampanel) in China for use in the adjunctive treatment of partial onset seizures in epilepsy patients. The drug is indicated for the adjunctive treatment of partial onset...read more